10-8055405-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001002295.2(GATA3):c.-251G>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.506 in 571,986 control chromosomes in the GnomAD database, including 76,623 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.44 ( 16244 hom., cov: 31)
Exomes 𝑓: 0.53 ( 60379 hom. )
Consequence
GATA3
NM_001002295.2 5_prime_UTR
NM_001002295.2 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.431
Genes affected
GATA3 (HGNC:4172): (GATA binding protein 3) This gene encodes a protein which belongs to the GATA family of transcription factors. The protein contains two GATA-type zinc fingers and is an important regulator of T-cell development and plays an important role in endothelial cell biology. Defects in this gene are the cause of hypoparathyroidism with sensorineural deafness and renal dysplasia. [provided by RefSeq, Nov 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BP6
Variant 10-8055405-G-A is Benign according to our data. Variant chr10-8055405-G-A is described in ClinVar as [Benign]. Clinvar id is 301109.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-8055405-G-A is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.626 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GATA3 | NM_001002295.2 | c.-251G>A | 5_prime_UTR_variant | 2/6 | ENST00000379328.9 | NP_001002295.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GATA3 | ENST00000379328.9 | c.-251G>A | 5_prime_UTR_variant | 2/6 | 1 | NM_001002295.2 | ENSP00000368632 | A1 | ||
GATA3 | ENST00000346208.4 | c.-251G>A | 5_prime_UTR_variant | 2/6 | 1 | ENSP00000341619 | P4 | |||
GATA3 | ENST00000481743.2 | c.-251G>A | 5_prime_UTR_variant | 2/3 | 2 | ENSP00000493486 | ||||
GATA3 | ENST00000643001.1 | c.-251G>A | 5_prime_UTR_variant | 2/2 | ENSP00000494284 |
Frequencies
GnomAD3 genomes AF: 0.442 AC: 67151AN: 151850Hom.: 16237 Cov.: 31
GnomAD3 genomes
AF:
AC:
67151
AN:
151850
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.529 AC: 221999AN: 420016Hom.: 60379 Cov.: 3 AF XY: 0.535 AC XY: 118733AN XY: 221762
GnomAD4 exome
AF:
AC:
221999
AN:
420016
Hom.:
Cov.:
3
AF XY:
AC XY:
118733
AN XY:
221762
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.442 AC: 67160AN: 151970Hom.: 16244 Cov.: 31 AF XY: 0.442 AC XY: 32870AN XY: 74292
GnomAD4 genome
AF:
AC:
67160
AN:
151970
Hom.:
Cov.:
31
AF XY:
AC XY:
32870
AN XY:
74292
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2223
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 31, 2019 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Hypoparathyroidism, deafness, renal disease syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at